Business
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in Raleigh, NC.
About this update from Avanos Medical, Inc.
[{"type":"text","content":"ALPHARETTA, Ga., July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in Raleigh, NC.","length":245,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Avanos Medical Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Avanos Medical Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":65,"url":"https://media.zenfs.com/en/prnewswire.com/a3171dfd9d9d08106baabe2b965e0542"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KRp2NVXwfDM6PDPsfmGn4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTExNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/a3171dfd9d9d08106baabe2b965e0542","width":400,"height":65}},"href":"https://mma.prnewswire.com/media/713850/Avanos_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This transaction aligns with Avanos' ongoing transformation, which is focused on advancing its strategic segments in Pain Management & Recovery and Specialty Nutrition Systems.","length":184,"tagName":"p"},{"type":"text","content":"The divested portfolio includes the TriVisc® and GenVisc® 850 injection products, which are indicated for the treatment of osteoarthritis (OA) pain in the knee. These injectable HA therapies are designed to help patients manage OA symptoms and improve joint function.","length":267,"tagName":"p"},{"type":"text","content":""This divestiture represents a meaningful step in advancing our transformation strategy and reinforcing our commitment to focused growth," said Dave Pacitti, Avanos' chief executive officer. "By aligning our product portfolio more closely with our strategic priorities, we expect to strengthen our ability to invest in those areas where we see the greatest potential to lead, innovate, and deliver long-term value for patients, customers, and shareholders."","length":481,"tagName":"p"},{"type":"text","content":"Channel-Markers Medical specializes in the development and commercialization of joint health, regenerative therapies, and minimally invasive pain management solutions. The acquisition of the HA portfolio supports CMM's strategic goal to expand its presence in musculoskeletal health and injectable pain therapies.","length":317...